Metyrapone-induced cardiovascular degenerative changes in non-arteriosclerotic and arteriosclerotic rats.
Virgin and breeder, male and female, Sprague-Dawley rats were unilaterally nephrectomized and given 1% saline drinking water. Animals were injected i.p., twice daily, with a 10 mg/100 g body wt dose of the 11-beta hydroxylation inhibitor, Metyrapone. After 7 weeks of treatment, both the previously nonarteriosclerotic virgin rats and the breeder rats with pre-existing arteriosclerosis developed de nove, widely distributed, intimal hyalinization of their peripheral arteries along with myocardial fibrosis and hyalinization of their intramyocardial coronary arteries. The Metyrapone-treated animals developed severe hypertension with greatly elevated serum creatin phosphokinase, glucose, BUN and cholesterol levels. The adrenal glands, hearts, and kidneys were greatly hypertrophied, in keeping with Metyrapone-induced extra ACTH release and the hypertension-induced myocardial and renal histopathology. Uniparous, Metyrapone-treated, female rats manifested an unusually high incidence of saccular aneurysms of the aorta. It is suggested that the hypertension and the intimal hyalinization and other specific morphologic characteristics of the cardiovascular degenerative changes observed were directly related to excess production of mineralocorticoids, e.g., deoxycorticosterone.
D000311:Adrenal Glands / Q000473:pathology; D000818:Animals; D001158:Arteries / Q000473:pathology; D001161:Arteriosclerosis / Q000097:blood / Q000150:complications; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003900:Desoxycorticosterone / Q000378:metabolism; D005260:Female; D006973:Hypertension / Q000139:chemically induced; D008055:Lipids / Q000097:blood; D008297:Male; D008797:Metyrapone / Q000633:toxicity*; D009929:Organ Size / Q000187:drug effects; D051381:Rats
D008055:Lipids; D003900:Desoxycorticosterone; D008797:Metyrapone